EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6 ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans

Sungyeun Bae iD, Ga-Yeong Lee iD, Eunsol Yang iD, Woori Chae iD, Kyung-Sang Yu iD, Joo-Youn Cho iD, Anhye Kim iD, Namyi Gu iD, SeungHwan Lee iD

Clinical and Translational Science · 2026

DOI: 10.1111/cts.70564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2026. Verfasst von Sungyeun Bae und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2D6, Venlafaxine Hydrochloride. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea (NRF), Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CYP2D6‐mediated drug–drug–gene interactions (DDGIs) are known to influence the pharmacokinetics of venlafaxine and its metabolism to O‐desmethylvenlafaxine. Solanidine and 3,4‐seco‐solanidine‐3,4‐dioic acid (SSDA) have recently been investigated as candidate endogenous CYP2D6 biomarkers; however, they remain unexplored in East Asian populations, where dietary potato intake is relatively lower than that in Western populations. A prospective clinical study aimed to characterize venlafaxine DDGIs and explore the potential of solanidine as a candidate biomarker of CYP2D6 activity in healthy Korean adults. Twenty participants including 14 CYP2D6 normal metabolizers (NMs) and 6 intermediate metabolizers (IMs)—all confirmed as CYP2C19 NMs—were enrolled. Serial plasma samples for pharmacokinetic assessment were collected before and after coadministration of paroxetine, a potent CYP2D6 inhibitor. Solanidine and SSDA were also measured in plasma and urine. Compared to CYP2D6 NMs, IMs exhibited higher venlafaxine exposure but lower O‐desmethylvenlafaxine exposure. Following CYP2D6 inhibition, phenotype‐dependent differences in venlafaxine and O‐desmethylvenlafaxine pharmacokinetics were attenuated. The metabolic ratio (MR) of plasma solanidine showed a modest positive correlation with both the MR of venlafaxine and CYP2D6 activity score. The MR of plasma solanidine decreased when CYP2D6 activity was reduced by paroxetine coadministration. These findings demonstrate phenotype‐dependent DDGIs of venlafaxine and suggest the exploratory potential of solanidine as an endogenous biomarker of CYP2D6 activity in the Korean population, despite relatively lower dietary exposure to potato‐derived precursors. This study provides preliminary evidence extending endogenous CYP2D6 biomarkers to an East Asian population with distinct dietary backgrounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP2D6Venlafaxine HydrochlorideAdultFemaleHumansMaleMiddle AgedYoung AdultBiomarkersDrug InteractionsParoxetineProspective StudiesRepublic of KoreaEast Asian PeopleDiosgenin

Stichwörter der Autor:innen

biomarkersdrug–drug interactionsdrug–gene interactionsparoxetine

Substanzen

BiomarkersCytochrome P-450 CYP2D6ParoxetineVenlafaxine HydrochloridesolanidineDiosgenin

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea.
  • Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, California, USA.
  • Department of Clinical Pharmacology and Therapeutics, CHA University CHA Bundang Medical Center, Seongnam, Republic of Korea.
  • Department of Pharmacology, CHA University School of Medicine, Pocheon, Republic of Korea.
  • Department of Clinical Pharmacology and Therapeutics, Dongguk University College of Medicine and Ilsan Hospital, Goyang, Republic of Korea.

ORCID-Profile: Sungyeun Bae, Ga-Yeong Lee, Eunsol Yang, Woori Chae, Kyung-Sang Yu, Joo-Youn Cho, Anhye Kim, Namyi Gu, SeungHwan Lee

Förderung

  • National Research Foundation of Korea (NRF)
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Bae, S., Lee, G. Y., Yang, E., Chae, W., Yu, K. S., Cho, J. Y., Kim, A., Gu, N., & Lee, S. (2026). Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6 ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans. Clinical and Translational Science. https://doi.org/10.1111/cts.70564

Vancouver

Bae S, Lee GY, Yang E, Chae W, Yu KS, Cho JY, et al. Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6 ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans. Clinical and Translational Science. 2026. doi:10.1111/cts.70564

BibTeX
@article{Bae2026,
  author = {Bae, Sungyeun and Lee, Ga-Yeong and Yang, Eunsol and Chae, Woori and Yu, Kyung-Sang and Cho, Joo-Youn and Kim, Anhye and Gu, Namyi and Lee, SeungHwan},
  title = {Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6 ‐Mediated Drug–Drug–Gene Interactions of Venlafaxine in Koreans},
  journal = {Clinical and Translational Science},
  year = {2026},
  doi = {10.1111/cts.70564}
}
Kostenlos starten →